Who owns the REVITOPE ONCOLOGY trademark?

The REVITOPE ONCOLOGY trademark is owned by Revitope Oncology, Inc..

What class is the REVITOPE ONCOLOGY trademark registered in?

The REVITOPE ONCOLOGY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for REVITOPE ONCOLOGY?

The USPTO serial number for REVITOPE ONCOLOGY is 90430529.

What is the registration number for REVITOPE ONCOLOGY?

REVITOPE ONCOLOGY is registered under USPTO registration number 0.

REVITOPE ONCOLOGY - Owned by Revitope Oncology, Inc. - (Class 005)

Full Goods & Services

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

This description is as filed with the USPTO and defines the scope of trademark protection.

Filing Basis & Declarations

Standard Characters ClaimedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1596255

480Apr 01, 2021

Source: USPTO Madrid International Filing Requests

Status History

37 events

ABANDONMENT - NO USE STATEMENT FILED

Oct 01, 2025

Code ABN6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 01, 2025

Code MAB6

SOU TEAS EXTENSION RECEIVED

Jun 14, 2024

Code EEXT

SOU EXTENSION 5 FILED

Jun 14, 2024

Code EXT5

SOU EXTENSION 5 GRANTED

Jun 14, 2024

Code EX5G

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 14, 2024

Code EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 16, 2023

Code EXRA

SOU TEAS EXTENSION RECEIVED

Dec 14, 2023

Code EEXT

SOU EXTENSION 4 FILED

Dec 14, 2023

Code EXT4

SOU EXTENSION 4 GRANTED

Dec 14, 2023

Code EX4G

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 16, 2023

Code EXRA

SOU TEAS EXTENSION RECEIVED

Jun 14, 2023

Code EEXT

SOU EXTENSION 3 FILED

Jun 14, 2023

Code EXT3

SOU EXTENSION 3 GRANTED

Jun 14, 2023

Code EX3G

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 16, 2022

Code EXRA

SOU TEAS EXTENSION RECEIVED

Dec 14, 2022

Code EEXT

SOU EXTENSION 2 FILED

Dec 14, 2022

Code EXT2

SOU EXTENSION 2 GRANTED

Dec 14, 2022

Code EX2G

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 16, 2022

Code EXRA

SOU TEAS EXTENSION RECEIVED

Jun 14, 2022

Code EEXT

SOU EXTENSION 1 FILED

Jun 14, 2022

Code EXT1

SOU EXTENSION 1 GRANTED

Jun 14, 2022

Code EX1G

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 14, 2021

Code NOAM

PUBLISHED FOR OPPOSITION

Oct 19, 2021

Code PUBO

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 19, 2021

Code NPUB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 29, 2021

Code NONP

EXAMINERS AMENDMENT -WRITTEN

Sep 14, 2021

Code CNEA

EXAMINERS AMENDMENT E-MAILED

Sep 14, 2021

Code GNEA

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 14, 2021

Code GNEN

EXAMINER'S AMENDMENT ENTERED

Sep 14, 2021

Code XAEC

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 14, 2021

Code CNSA

NON-FINAL ACTION WRITTEN

Jul 11, 2021

Code CNRT

NON-FINAL ACTION E-MAILED

Jul 11, 2021

Code GNRT

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 11, 2021

Code GNRN

ASSIGNED TO EXAMINER

Jun 20, 2021

Code DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 24, 2021

Code NWOS

NEW APPLICATION ENTERED

Jan 02, 2021

Code NWAP

Other Marks by Revitope Oncology, Inc.

Additional USPTO filings from the same owner.

LOG

LogoMark

90407765

Revitope Oncology, Inc.

REGISTERED

REV

REVITOPE ONCOLOGY

90430409

Revitope Oncology, Inc.

REGISTERED

PRE

PRECISIONGATE

90479940

Revitope Oncology, Inc.

ABANDONED

ONE

ONEGATE

90468677

Revitope Oncology, Inc.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

DIA

DIAKONOS ONCOLOGY

98253483

Diakonos Oncology Corporation

REGISTERED

RAD

RADIONETICS ONCOLOGY

97085639

Radionetics Oncology, Inc.

REGISTERED

RAD

RADIONETICS ONCOLOGY

97085642

Radionetics Oncology, Inc.

REGISTERED

ALX

ALX ONCOLOGY

87822154

ALX Oncology, Inc.

REGISTERED

Other Marks by Monica Riva Talley

Additional USPTO filings handled by the same attorney of record.

CIR

CIRQUE DU SOLEIL

98639710

REGISTERED

GAT

GATES AG ONE

98928216

REGISTERED

BOU

BOURBONALITY

88714234

REGISTERED

HUG

HUGO

79173124

REGISTERED

REVITOPE ONCOLOGY

Full Goods & Services

Filing Basis & Declarations

International Filings

Other Marks by Revitope Oncology, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Monica Riva Talley

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Industries

USPTO Deadlines

Compare

Resources

Company

Exceptions